|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Jan 1, 2023
|
|
|---|---|---|---|---|
| OPERATING ACTIVITIES: | ||||
| Net (loss) income | ||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||
| Depreciation and amortization | ||||
| Goodwill impairment charge | ||||
| Asset impairment charge | ||||
| Stock-based compensation expense | ||||
| Change in deferred tax assets and liabilities | ||||
| Net change in operating lease right-of-use assets and liabilities | ||||
| Payment of accreted interest on contingent and deferred consideration | ||||
| Loss on extinguishment of debt | ||||
| Unwind inventory fair value adjustment | ||||
| Asset write off related to restructuring, integration and other charges | ||||
| Asset write off related to tax assessment refund | ||||
| Other non-cash, net | ||||
| Changes in assets and liabilities: | ||||
| Accounts receivable | ||||
| Inventories | ||||
| Prepaid expenses and other current and non-current assets | ||||
| Accounts payable | ||||
| Accrued payroll and related expenses | ||||
| Income taxes payable | ||||
| Other current and non-current liabilities | ||||
| Net cash provided by operating activities | ||||
| INVESTING ACTIVITIES | ||||
| Acquisitions of property, plant, equipment, investments and intangibles | ||||
| Proceeds from held for sale asset, net of costs to sell | ||||
| Acquisition of businesses, net of cash and restricted cash acquired | ||||
| Proceeds from government assistance allocated to fixed assets | ||||
| Purchases of marketable securities | ||||
| Proceeds from sale of marketable securities | ||||
| Loan to LEX Diagnostics | ||||
| Net cash used for investing activities | ||||
| FINANCING ACTIVITIES | ||||
| Proceeds from issuance of common stock | ||||
| Short-term borrowings, net | ||||
| Revolving credit facility, net | ||||
| Proceeds from long-term borrowings, net of discount and debt issuance costs | ||||
| Payments on long-term borrowings | ||||
| Payments of tax withholdings related to vesting of stock-based awards | ||||
| Repurchases of common stock | ||||
| Principal payments of acquisition contingent consideration | ||||
| Principal payments of deferred consideration | ||||
| Net cash provided by (used for) financing activities | ||||
| Effect of exchange rates on cash | ||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash at beginning of period | ||||
| Cash, cash equivalents and restricted cash at end of period | ||||
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | ||||
| Cash paid during the period for interest | ||||
| Cash (received) paid for income taxes during the period | ||||
| Purchase of property, equipment and intangibles by incurring current liabilities | ||||
| Transfer of instrument inventories to property, plant and equipment | ||||
| Reduction of other current liabilities upon issuance of restricted share units | ||||
| Initial recognition of finance lease right-of-use asset and liability | ||||
Loading...
